World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Molecular Biology 56 2196 1976 79 64 177 13418

Marc Piechaczyk publications per year

The chart shows the history of publications by Marc Piechaczyk between 1980 and 2023, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Marc Piechaczyk published across 44 years, from 1980 to 2023, averaging 5 papers a year. Output peaked at 40 publications in 2023. 43 of the 218 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 1980 to 2023. Vertical axis: number of publications, 0 to 40. Peak 40 publications in 2023. 1980: 1 publication 1981: 0 publications 1982: 3 publications 1983: 1 publication 1984: 7 publications 1985: 8 publications 1986: 3 publications 1987: 2 publications 1988: 7 publications 1989: 11 publications 1990: 5 publications 1991: 3 publications 1992: 6 publications 1993: 2 publications 1994: 5 publications 1995: 5 publications 1996: 4 publications 1997: 5 publications 1998: 6 publications 1999: 2 publications 2000: 5 publications 2001: 6 publications 2002: 5 publications 2003: 6 publications 2004: 3 publications 2005: 6 publications 2006: 3 publications 2007: 2 publications 2008: 11 publications 2009: 1 publication 2010: 8 publications 2011: 1 publication 2012: 2 publications 2013: 5 publications 2014: 4 publications 2015: 2 publications 2016: 4 publications 2017: 1 publication 2018: 4 publications 2019: 5 publications 2020: 2 publications 2021: 3 publications 2022: 3 publications 2023: 40 publications
1980 2023

218 publications in total across all disciplines

View publications per year as a table
Marc Piechaczyk: publications per year, 1980 to 2023
Year Publications
1980 1
1981 0
1982 3
1983 1
1984 7
1985 8
1986 3
1987 2
1988 7
1989 11
1990 5
1991 3
1992 6
1993 2
1994 5
1995 5
1996 4
1997 5
1998 6
1999 2
2000 5
2001 6
2002 5
2003 6
2004 3
2005 6
2006 3
2007 2
2008 11
2009 1
2010 8
2011 1
2012 2
2013 5
2014 4
2015 2
2016 4
2017 1
2018 4
2019 5
2020 2
2021 3
2022 3
2023 40
Total 218
Download as CSV

Marc Piechaczyk publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Marc Piechaczyk sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 53 bars. Horizontal axis: publications, 47–56 to 564+. Vertical axis: number of scientists, 0 to 177. Most scientists, 177, have 117–126 publications. The last bar groups every scientist with 564 publications or more. The highlighted bar, 177–186 publications, is where this scientist sits. 47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47–56 publications 564+

This scientist: 177 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

View publications distribution as a table
Number of Molecular Biology scientists by publication count, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
Publications Scientists This scientist
47–56 7
57–66 17
67–76 65
77–86 90
87–96 125
97–106 131
107–116 162
117–126 177
127–136 158
137–146 158
147–156 146
157–166 159
167–176 131
177–186 110 177
187–196 112
197–206 100
207–216 89
217–226 98
227–236 74
237–246 72
247–256 63
257–266 53
267–276 54
277–286 49
287–296 52
297–306 43
307–316 46
317–326 41
327–336 42
337–346 31
347–356 28
357–366 29
367–376 26
377–386 24
387–396 24
397–406 14
407–416 13
417–426 20
427–436 12
437–446 20
447–456 11
457–466 10
467–476 14
477–486 14
487–496 10
497–506 13
507–516 13
517–526 2
527–536 4
537–546 6
547–556 8
557–563 6
564+ 100
Download as CSV

Marc Piechaczyk D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Marc Piechaczyk sits on this spectrum.

No. of scientists
25 50 75 100 125
Bar chart with 54 bars. Horizontal axis: D-Index, 40–41 to 145+. Vertical axis: number of scientists, 0 to 131. Most scientists, 131, have 64–65 D-Index. The last bar groups every scientist with 145 D-Index or more. The highlighted bar, 56–57 D-Index, is where this scientist sits. 40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40–41 D-Index 145+

This scientist: 56 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

View D-Index distribution as a table
Number of Molecular Biology scientists by D-index, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
D-Index Scientists This scientist
40–41 36
42–43 101
44–45 115
46–47 121
48–49 118
50–51 130
52–53 106
54–55 116
56–57 113 56
58–59 129
60–61 120
62–63 105
64–65 131
66–67 95
68–69 97
70–71 106
72–73 83
74–75 89
76–77 77
78–79 70
80–81 73
82–83 60
84–85 48
86–87 45
88–89 50
90–91 31
92–93 51
94–95 43
96–97 38
98–99 39
100–101 41
102–103 29
104–105 33
106–107 35
108–109 20
110–111 38
112–113 19
114–115 28
116–117 13
118–119 23
120–121 16
122–123 15
124–125 11
126–127 21
128–129 7
130–131 13
132–133 14
134–135 17
136–137 9
138–139 8
140–141 16
142–143 7
144 7
145+ 100
Download as CSV

Overview

Marc Piechaczyk is affiliated with the Centre national de la recherche scientifique (CNRS) in France. Their research encompasses areas within Biochemistry, Genetics and Molecular Biology, as well as Medicine, with a focus on Molecular Biology, Oncology, Immunology, Hematology, and Genetics as subfields.

The principal topics of their work include:

  • Ubiquitin and proteasome pathways
  • Histone Deacetylase Inhibitors Research
  • Peptidase Inhibition and Analysis
  • Genomics and Chromatin Dynamics
  • Acute Myeloid Leukemia Research
  • Protein Degradation and Inhibitors
  • Cancer-related Molecular Pathways

Marc Piechaczyk has authored multiple papers in various scientific journals. Notable recent publications include:

  • SUMO and Transcriptional Regulation: The Lessons of Large-Scale Proteomic, Modifomic and Genomic Studies, 2021, Molecules
  • Fra-1 regulates its target genes via binding to remote enhancers without exerting major control on chromatin architecture in triple negative breast cancers, 2021, Nucleic Acids Research
  • New roles for AP-1/JUNB in cell cycle control and tumorigenic cell invasion via regulation of cyclin E1 and TGF-β2, 2022, Genome Biology
  • The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of acute myeloid leukemias, 2022, Haematologica
  • Ubiquitin, SUMO, and Nedd8 as Therapeutic Targets in Cancer, 2020, Advances in Experimental Medicine and Biology

The frequent co-authors collaborating with Marc Piechaczyk are:

  • Guillaume Bossis
  • Mathias Boulanger
  • Guillaume Cartron
  • Denis Tempé
  • Ludovic Gabellier

Their research has been published predominantly in the following venues:

  • Nucleic Acids Research
  • Haematologica
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Molecules
  • Genome Biology

Best Publications

  • Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family

    Ph. Fort;L. Marty;M. Piechaczyk;S.El Sabrouty

  • Extreme instability of myc mRNA in normal and transformed human cells.

    C. H. Dani;J. M. Blanchard;M. Piechaczyk;S. El Sabouty

  • Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissues

    M. Piechaczyk;J. M. Blanchard;L. Marty;C.-H. Dani

  • Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control.

    M Bouaboula;P Legoux;B Pességué;B Delpech

  • CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion.

    Anne Doye;Amel Mettouchi;Guillaume Bossis;René Clément

  • c-myc gene is transcribed at high rate in G0-arrested fibroblasts and is post-transcriptionally regulated in response to growth factors.

    Jean-Marie Blanchard;Marc Piechaczyk;Christian Dani;Jean-Claude Chambard

  • Posttranscriptional mechanisms are responsible for accumulation of truncated c-myc RNAs in murine plasma cell tumors.

    Marc Piechaczyk;Jian-Qing Yang;Jean-Marie Blanchard;Philippe Jeanteur

  • The HBZ Factor of Human T-cell Leukemia Virus Type I Dimerizes with Transcription Factors JunB and c-Jun and Modulates Their Transcriptional Activity

    Jihane Basbous;Charlotte Arpin;Gilles Gaudray;Marc Piechaczyk

  • Ubiquitin-independent degradation of proteins by the proteasome.

    Isabelle Jariel-Encontre;Guillaume Bossis;Marc Piechaczyk

  • A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses

    Pierre Roux;Philippe Jeanteur;Marc Piechaczyk

  • The AP-1 transcriptional complex: Local switch or remote command?

    Fabienne Bejjani;Emilie Evanno;Kazem Zibara;Marc Piechaczyk

  • Regulation of c-fos gene expression in hamster fibroblasts: initiation and elongation of transcription and mRNA degradation

    Philippe Fort;Jocelyne Rech;Annick Vie;Marc Piechaczyk

  • Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.

    Guillaume Bossis;Cécile E. Malnou;Rosa Farras;Elisabetta Andermarcher

  • Proteolysis by calpains: a possible contribution to degradation of p53.

    M Pariat;S Carillo;M Molinari;C Salvat

  • SUMO under stress

    Denis Tempé;Marc Piechaczyk;Guillaume Bossis

  • Ubiquitinylation is not an absolute requirement for degradation of c- Jun protein by the 26 S proteasome

    I Jariel-Encontre;M Pariat;F Martin;S Carillo

  • c-fos proto-oncogene regulation and function

    Marc Piechaczyk;Jean-Marie Blanchard

  • Nuclear localization of c-Fos, but not v-Fos proteins, is controlled by extracellular signals

    Pierre Roux;Jean-Marie Blanchard;Anne Fernandez;Ned Lamb

  • Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives

    D Eick;M Piechaczyk;B Henglein;J M Blanchard

  • Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins.

    Mariana Marin;Danièle Noël;Sandrine Valsesia-Wittman;Frédérique Brockly

Frequent Co-Authors

Christian Recher
Christian Recher Federal University of Toulouse Midi-Pyrénées
Carmen Garrido
Carmen Garrido University of Burgundy
Anne Fernandez
Anne Fernandez Centre national de la recherche scientifique, CNRS
Jacques Landry
Jacques Landry Université Laval
Manuel S. Rodriguez
Manuel S. Rodriguez Centre national de la recherche scientifique, CNRS
Ned J. C. Lamb
Ned J. C. Lamb Centre national de la recherche scientifique, CNRS
James Hughes
James Hughes Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you consider a career in Molecular Biology, you may want to explore related online degrees and health science pathways. Many students begin or enhance their credentials through accelerated online nursing or science-based programs that offer flexibility and reputable curricula.

For registered nurses seeking advancement, a popular option is a 6-month rn to bsn program. These intensive courses are designed for those who already have clinical experience and want to move quickly into higher-level roles.

Those holding an associate degree in nursing might consider asn to np programs, which bridge the gap to advanced nursing practice and open doors to specialized healthcare fields. In addition, non-nurses interested in a career pivot can look into direct entry msn programs online, which provide an accelerated path to a master's in nursing regardless of prior undergraduate major.

Comparing institutions is also critical. For insight into online nursing education, review the differences between capella vs chamberlain rn to bsn to determine the best fit for your academic and professional goals.

Exploring these pathways can help you diversify your skills and expand your career opportunities both inside and outside the lab.

Best Scientists Citing Marc Piechaczyk

Trending Scientists

Recently Published Articles